Product Search |
|
| Input Product Name Or Cas No. |
Category |
Products |
5-Bromo-2-phenyl-9,9′-spirobi[9H-fluor |
2-Chloro-5-phenyl-9,9′-spirobi[9H-fluo |
4,6-Diphenyl-2-pyrimidinecarboxaldehyde |
2-Chloro-4,6-di-2-pyridinylpyrimidine |
Methyl 2-(4-cyanophenyl)-4,5-dihydro-5-o |
Ethyl 3-[bis[4-(dimethylamino)phenyl]met |
N,N′-Bis(1-methylpropyl)propanimidamid |
6-Bromo-2-(4-iodophenyl)-1H-benz[de]isoq |
1-(1-Butoxy-2-propoxy)-2-propanol |
Tributylmethylammonium bis(trifluorometh |
1,1′-[[3-(Dimethylamino)propyl]imino]b |
2-Octylphenol |
2,2′-Methylenebis(4-methyl-6-cyclohexy |
2,2′-(1,6-Hexanediyl)bis[oxirane] |
Morpholine, 4-ethyl-, 4-oxide |
Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]-, |
1,1-Dimethylethyl 2-propeneperoxoate |
1-[1-Methyl-2-(1-methylethoxy)ethoxy]-2- |
N,N′-Bis(1,1-dimethylethyl)methanimida |
2-Methoxy-2-methyl-1-butanol |
N,N′-Bis(1-methylpropyl)ethanimidamide |
N,N′-Bis(2-methylpropyl)ethanimidamide |
N,N′-Bis(2-methylpropyl)methanimidamid |
1,3-Diethyl-2,3-dihydro-2,2-dimethyl-1H- |
2-[(E)-[(3-Ethynylphenyl)imino]methyl]ph |
1,3-Diethyl-2,3-dihydro-2,2-dimethyl-1H- |
4,4’-(1-(4-(1-(4-hydroxyphenyl)ethyl)p |
2-Hydroxy-6-[(1-methylethyl)thio]-1H-ben |
3-Methoxybutyl 3-[[2,3-dihydro-1,3-dioxo |
1,3,5-Tris[2-(3-mercaptopropoxy)ethyl]-1 |
4,4′-Decylidenebis[phenol] |
6-(Propylthio)-1H,3H-naphtho[1,8-cd]pyra |
N,N,N-trimethylpyridin-4-aminium trifluo |
N,N,N-trimethylnaphthalen-1-aminium chlo |
3,4-difluorobenzyl 5-(trimethoxysilyl)bi |
1,1′-Sulfinylbis[4-(trimethylsilyl)ben |
tert-butyl 5-(trimethoxysilyl)bicyclo[2. |
N1,N1-Bis[4-(dimethylamino)phenyl]-N4,N4 |
4-(2,3-Dihydro-1,3-dimethyl-1H-benzimida |
N,N,N-triethylbenzenaminium iodide |
N,N-dimethyl-N-phenylbenzenaminium chlor |
4-[[(2Z)-2-Bromobut-2-enoyl]amino]-2-flu |
2-Ethyl 4-propyl 5-amino-1H-imidazole-2, |
Ethyl 5-amino-2-[[[2-(dimethylamino)ethy |
Ethyl 5-amino-2-[(propylamino)carbonyl]- |
Ethyl 5-amino-2-[(methylamino)carbonyl]- |
Ethyl 5-amino-2-[[(1-methylethyl)amino]c |
Ethyl 5-amino-2-[(dimethylamino)carbonyl |
Ethyl 5-amino-2-(1-pyrrolidinylcarbonyl) |
Ethyl 5-amino-2-[[(phenylmethyl)amino]ca |
|
Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| NX69941 | 7-bromo-2H-benzo[1,4]oxazin-3(4H)-one | 321436-06-0 | 95% |
| NX69942 | 1,5-diiodoNaphthalene | 27715-44-2 | 95% |
| NX69943 | 2-Chloro-5-Hydroxy-6-Nitropyridine | 887471-39-8 | 95% |
| NX69944 | 7-fluoro-2H-benzo[1,4]oxazin-3(4H)-on | 103361-99-5 | 95% |
| NX69945 | 7-Iodo-2H-1,4-benzoxazin-3(4H)-one | 874840-87-6 | 95% |
| NX69946 | 7-bromo-2,3-dihydro-1,8-naphthyridin-4(1H)-one | 64942-87-6 | 95% |
| NX69947 | 4-hydroxy-4-(trifluoromethyl)cyclohexanecarboxylic acid | 1163729-47-2 | 95% |
| NX69948 | 3-Hydroxy-3-(trifluoromethyl)cyclobutanecarboxylic acid | 1163729-49-4 | 95% |
| NX69949 | 1-Methyltetrazole | 16681-77-9 | 95% |
| NX69950 | 7-chloro-2,3-dihydro-1,8-naphthyridin-4(1H)-one | 76629-10-2 | 95% |
| NX69951 | 6-chloro-5-methylpyridazin-3(2H)-one | 1703-07-7 | 95% |
| NX69952 | (S)-2-Hydroxybutanoic acid N-Butyl ester | 132513-51-0 | 95% |
| NX69953 | 3-Ethyl-1-methyl-1H-imidazolium perchlorate | 65039-04-5 | 95% |
| NX69954 | 1-Butyl-3-methylimidazolium hexafluoroantimonate | 174645-81-9 | 95% |
| NX69955 | 1-propyl-3-methylimidazolium tetrafluoroborate | | 95% |
| NX69956 | 1,2,4-Triazolo[4,3-a]pyridine-3-methanamine | 91981-59-8 | 95% |
| NX69957 | 8-chloroimidazo[1,2-a]pyridine-2-carboxylic acid | 1020038-45-2 | 95% |
| NX69958 | 4-Propyl-naphthalen-1-carboxylic acid | 107777-22-0 | 95% |
| NX69959 | 8-Methoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | 32178-63-5 | 95% |
| NX69960 | KB-R7943 mesylate | 182004-65-5 | 95% |
| NX69961 | NS309 | 18711-16-5 | 95% |
| NX69962 | H 89 dihydrochloride | 127243-85-0 | 95% |
| NX69963 | RS 504393 | 300816-15-3 | 95% |
| NX69964 | L-694,247 | 137403-12-4 | 95% |
| NX69965 | SB714786 | 584555-10-2 | 95% |
| NX69966 | GBR-12935 | 76778-22-8 | 95% |
| NX69967 | RS 127445 hydrochloride | 199864-87-4 | 95% |
| NX69968 | Diclofensine | 67165-56-4 | 95% |
| NX69969 | BML 190 | 2854-32-2 | 95% |
| NX69970 | AM 630 | 164178-33-0 | 95% |
|
|
|
|